To confirm clinical relevance of HER2 expression in NSCLC, we used IHC to assess HER2 expression in NSCLC specimens obtained from bronchoscopic lung biopsy, and analyzed its correlation with clinic-pathological parameters. The gene discussed is ERBB2; the disease is non-small cell lung carcinoma.